Ironwood Pharmaceuticals, Inc.
IRWD
$0.57
-$0.0244-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 96.93% | 100.09% | 99.74% | 101.00% | -678.16% |
| Total Depreciation and Amortization | 9.71% | 27.68% | 45.26% | 30.10% | 33.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.12% | -91.45% | -91.42% | -90.97% | 1,082.34% |
| Change in Net Operating Assets | -50.57% | -96.80% | 15.80% | 43.75% | 332.61% |
| Cash from Operations | -47.03% | -43.55% | -45.25% | -44.29% | -48.85% |
| Capital Expenditure | 67.99% | 47.99% | -908.57% | -642.31% | -134.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 99.61% | 97.34% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.99% | 99.99% | 99.58% | 97.30% | -733,023.57% |
| Total Debt Issued | -62.50% | -62.50% | -62.50% | -62.50% | -- |
| Total Debt Repaid | -92.00% | -165.00% | -266.67% | -- | -3.56% |
| Issuance of Common Stock | -92.30% | 73.24% | 44.62% | 32.07% | 4.52% |
| Repurchase of Common Stock | 80.36% | -- | -- | -- | 98.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.31% | 92.31% | -1,166.14% | -1,072.20% | -- |
| Cash from Financing | -135.48% | -138.60% | -143.22% | -146.92% | 280.54% |
| Foreign Exchange rate Adjustments | -117.24% | 39.62% | -3,333.33% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.90% | 99.36% | 94.99% | 78.42% | -522.22% |